American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease

• Published in: Endocrine practice Vol. 23; no. Suppl 2; pp. 1 - 87
• Main Authors: Jellinger, Paul S., Handelsman, Yehuda, Rosenblit, Paul D., Bloomgarden, Zachary T., Fonseca, Vivian A., Garber, Alan J., Grunberger, George, Guerin, Chris K., Bell, David S.H., Mechanick, Jeffrey I., Pessah-Pollack, Rachel, Wyne, Kathleen, Smith, Donald, Brinton, Eliot A., Fazio, Sergio, Davidson, Michael, Davidson, Michael H., Smith, Donald A., Bush, Michael, Zangeneh, Farhad
• Format: Journal Article
• Language: English
• Published: United States Elsevier Limited 01.04.2017
• Subjects: Cardiovascular disease; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dyslipidemias; Endocrinologists; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metabolic disorders; Practice Guidelines as Topic; Proprotein Convertase 9; Prospective Studies; United States; United States

The development of these guidelines is mandated by the American Association of Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology (ACE) Board of Trustees and adheres with published AACE protocols for the standardized production of clinical practice guidelines (...